"The Lehigh Center opened its doors in 2001. Since then we have grown into the largest independently run research facility in the Lehigh Valley. We credit this success to our highly trained staff of doctors, nurses and study coordinators who believe that the health and wellbeing of our patients is of the utmost importance, while we obtain quality data. At the Lehigh Center for Clinical Research we understand you have made the decision to be a part of our study team for many reasons and expect a pleasurable study experience. We will always do our best to accommodate your needs. Our team is always on call if you have any questions or concerns."

During the past decade, Lehigh Center for Clinical Research conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 25 clinical trials were completed, i.e. on average, 65.8% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 13 clinical trials were completed. i.e. 81.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lehigh Center for Clinical Research" #1 sponsor was "Shire" with 6 trials, followed by "Sunovion" with 6 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Naurex, Inc, an affiliate of Allergan plc" with 5 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lehigh Center for Clinical Research" #1 collaborator was "Premier Research Group plc" with 2 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator, "Otsuka America Pharmaceutical" with 1 trials as a collaborator and "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Lehigh Center for Clinical Research" are "Major Depressive Disorder" (11 trials), "Depressive Disorder, Major" (9 trials), "Alzheimer's Disease" (6 trials), "Binge Eating Disorder" (6 trials) and "Depression" (4 trials). Many other conditions were trialed in "Lehigh Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "Lehigh Center for Clinical Research" are "Drug" (56 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Rapastinel" (4 trials), "placebo" (3 trials), "Aticaprant" (2 trials) and "Atogepant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lehigh Center for Clinical Research" are 56 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Lehigh Center for Clinical Research". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 32 completed trials in Lehigh Center for Clinical Research, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Lehigh Center for Clinical Research, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 1 trials that are defined as “Not Applicable".